SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-036722
Filing Date
2014-11-18
Accepted
2014-11-18 17:43:48
Documents
1
Period of Report
2014-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - ALAFI CAPITAL COMPANY, LLC rrd419005.html 4  
1 FORM 4 - ALAFI CAPITAL COMPANY, LLC rrd419005.xml 4 4243
  Complete submission text file 0001181431-14-036722.txt   5715
Mailing Address PO BOX 7338 BERKELEY CA 94707
Business Address
ALAFI CAPITAL CO LLC (Reporting) CIK: 0001216017 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 141232979

Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations